Clinical Trials Logo

Retinal Detachment clinical trials

View clinical trials related to Retinal Detachment.

Filter by:

NCT ID: NCT05561569 Recruiting - Retinal Detachment Clinical Trials

Air Versus Gas Tamponade in Primary Retinal Detachment

Start date: September 26, 2022
Phase: N/A
Study type: Interventional

Management of primary retinal detachment due to upper retinal break is one of controversial situation that may face ophthalmologists in vitreoretinal subspecialty.

NCT ID: NCT05543018 Recruiting - Glaucoma Clinical Trials

Effect of Intraocular Tamponade on Visual Perception

Start date: September 12, 2022
Phase: N/A
Study type: Interventional

Intraocular tamponade used in vitrectomy operations may affects retinal function in various mechanisms.

NCT ID: NCT05523869 Recruiting - Clinical trials for Proliferative Vitreoretinopathy in Rhegmatogenous Retinal Detachment

Intravitreal Topotecan in the Repair of Rhegmatogenous Retinal Detachment With Proliferative Vitreoretinopathy

TOPO-RD
Start date: February 23, 2023
Phase: Phase 2
Study type: Interventional

Intravitreal topotecan has anti-inflammatory, anti-proliferative and anti-fibrotic activity that we hypothesize may exhibit high efficacy for the treatment of proliferative vitreoretinopathy (PVR) in patients with rhegmatogenous retinal detachment (RRD). A high efficacy for intravitreal topotecan has been exhibited in cell cultures of PVR. At the same time, intravitreal topotecan has been routinely used in the treatment of vitreous seeds from retinoblastoma. At doses of 5-30 micrograms per injection, no adverse events have been reported with the use of intravitreal topotecan. Therefore, the current prospective matched phase II trial aims to investigate the efficacy and safety of intravitreal topotecan for severe PVR in patients with RRD.

NCT ID: NCT05514925 Recruiting - Clinical trials for Proliferative Diabetic Retinopathy

Cryoapplication Versus Anti-VEGF Before Diabetic Vitrectomy

Start date: November 21, 2017
Phase: Phase 4
Study type: Interventional

Pars-plana vitrectomy (PPV) is the cornerstone of surgical treatment for eyes with complicated proliferative diabetic retinopathy. Anti-VEGF intravitreal injection before PPV has shown a good effect on surgical outcomes. However, many patients present with co-morbidities that contraindicate the usage of anti-VEGF in the pre-operative period. Thus, cryoapplication, an old therapeutic tool for proliferative diabetic retinopathy may be a good alternative. The investigators present herein a comparative study between peripheral retinal cryoapplication and anti-VEGF before vitrectomy for complicated proliferative diabetic retinopathy.

NCT ID: NCT05331664 Recruiting - Clinical trials for Rhegmatogenous Retinal Detachment

Dropless Pars Plana Vitrectomy Study

DVS
Start date: July 25, 2022
Phase: Phase 4
Study type: Interventional

To demonstrate that intraoperative use of subtenon triamcinolone acetonide at the time of surgery without postoperative eye drops is non-inferior to the regimen of postoperative eye drops following primary pars plana vitrectomy for retinal detachment.

NCT ID: NCT05130385 Recruiting - Glaucoma Clinical Trials

High Resolution Optical Coherence Tomography

Start date: November 30, 2021
Phase:
Study type: Observational

Comparison of high-resolution optical coherence tomography (High-Res-OCT) to conventional imaging modalities for the diagnosis of eye diseases

NCT ID: NCT05069675 Recruiting - Clinical trials for Cystoid Macular Edema

Cystoid Macular Edema After Vitrectomy for Rhegmatogenous Retinal Detachment

Start date: July 12, 2021
Phase:
Study type: Observational

To investigate the incidence of cystoid macular edema in eyes with primary rhegmatogenous retinal detachment successfully treated with vitrectomy with gas tamponade, and to evaluate the clinical variables associated with its development.

NCT ID: NCT04774146 Recruiting - Retinal Detachment Clinical Trials

Quantification of Silicone Oil Emulsification After Pars Plana Vitrectomy

Start date: June 1, 2021
Phase:
Study type: Observational

silicone oil tamponade removal after previous injection of complicated retinal detachment can be achieved with active suction followed by triple air-fluid exchange or prolonged lavage of the vitreous chamber to remove emulsification. Purpose of the study is to compare the amount of silicone oil emulsification droplets within the lavage fluid in case of air exchange and simple lavage to compare which technique removed the highest percentage of emulsion. This is achieved by comparing consecutive samples of lavage fluid

NCT ID: NCT04723420 Recruiting - Clinical trials for Rhegmatogenous Retinal Detachment

Pneumatic Retinopexy for Primary Rhegmatogenous Retinal Detachment: To Steamroll or Not

Start date: August 7, 2020
Phase: N/A
Study type: Interventional

This is a randomized controlled trial comparing displacement of macula and the rapidity of reattachment of macula between two different positioning techniques after pneumatic retinopexy : Direct technique (patient is positioned so that the bubble is immediately placed directly over the retina break) and Steamroller technique (patient is initially positioned face down for 4-6 hours and subsequently changes their head position so that the bubble is then placed directly over the retina break).

NCT ID: NCT04676256 Recruiting - Retinal Detachment Clinical Trials

Early VItrectomy in DENse Spontaneous Vitreous HEmorrhage

EVIDENSE
Start date: July 2, 2021
Phase: N/A
Study type: Interventional

The aim of the protocol is to compare the ocular outcomes after spontaneous vitreous hemorrhage treated with an early vitrectomy versus ultrasound monitoring with late vitrectomy. The hypothesis is that an early vitrectomy could decrease the rate of retinal detachment occurring after a spontaneous vitreous hemorrhage.